February 17, 2025
Abby Reynolds, Chief Experience Officer at Pleio, explores how pharma companies can address America’s loneliness epidemic by embracing human-first, peer-to-patient engagement models.
January 9, 2025
“Technology helps us be more efficient in terms of the patients we target, the words we choose, and the times we call. So, our view on technology is we use technology to support human interaction and make it better, optimize it, and make it more efficient, but not replace it.” – Michael Oleksiw, CEO at Pleio
December 22, 2024
The best “gift” for a person with chronic conditions is the emotional support and education needed to stay adherent to medications during the hectic holiday season. Dr. Bram Greenberg, Chief Medical Officer at Pleio, contributes a thoughtful byline in MedCity News ahead of the holiday season.
December 18, 2024
In this PharmaPhorum byline, Pleio’s Chief Experience Officer Abby Reynolds explores how pharmaceutical companies can better support patients using GLP-1s by addressing the emotional barriers to weight loss. From stigma and social isolation to misinformation and adherence challenges, Reynolds makes the case for human-first, personalized patient support programs that foster connection, resilience, and real-world success with GLP-1 therapy.
December 12, 2024
“Peer-to-patient platforms use the benefits of human-first support with the power of technology to inform and enhance human interactions. For example, use of conversational analysis and conversational intelligence—powered by the latest in AI technology—helps us both understand the structure of conversation and promote effective and empathic communication with patients. Still, I see the greatest opportunity in utilizing AI to improve human interactions, not replace them.” – Abby Reynolds, Chief Experience Officer at Pleio
November 20, 2024
“Digital health plays a major role in shaping, extending and facilitating human connections. This patient-centered approach will lead to better outcomes, where adherence is driven not by obligation but by a genuine partnership in the patient’s health journey.” – Michael Oleksiw, Chief Executive Officer at Pleio
FOR MEDIA INQUIRIES PLEASE EMAIL [email protected].